MULTIPLE SCLEROSIS ITALIAN REGISTER

9.30 - 9.45 - Introduction
Mario Alberto Battaglia
9.45 - 10.15 - Maria Trojano
Real World Studies: opportunity, challenges and critical issue

10.15 - 10.45 | DESCRIPTIVE EPIDEMIOLOGY

Chairs: Maura Pugliatti, Monica Ulivelli

10.15 - 10.30 - Paola Mosconi
The use of a roving EDSS reference value to enhance detection of EDSS worsening events: A real world evaluation through the Italian MS Register
10.30 - 10.45 - Pietro Iaffaldano
INTEREST: Italian Multiple Sclerosis Registry non interventional retrospective analysis in secondary progressive MS

10.45 - 12.45 | THERAPY OPTIMIZATION

Chairs: Maria Pia Amato, Marco Capobianco

10.45 - 11.00 - Francesca Caputo
Profiling treatment choices in MS during two different eras: a real world assessment in the Italian MS Registry
11.00 - 11.15 - Alessia Manni
INSPIRA - Italian analysis of the National multiple sclerosis registry Studying the concept of Progression Independent from Relapse Activity
11.15 - 11.30 - Pietro Iaffaldano
Early-aggressive treatment algorithm versus classical escalation therapy in relapsing multiple sclerosis
11.30 - 11.45 - Maria Pia Amato
Assessing efficacy and safety of treatments in progressive MS
11.45 – 12.00 - Damiano Paolicelli
Retrospective study to evaluate the long-term impact of different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis. Italian IMedWeb MS Registry. RE.LO.DI.MS Study
12.00 - 12.15 - Francesco Patti
Retrospective pilot study on long-term Cladribine effects in patients with relapsing remitting multiple sclerosis or clinically isolated syndrome
12.15 - 12.30 - Diana Ferraro
Risks associated with wash-out duration when switching from fingolimod to cell-depleting agents
12.30 - 12.45 - Marzia Romeo
Predictive factors of disability progression in a large cohort of Italian MS patients

12.45 - 13.15 | RARE FORMS OF MS

Chairs: Roberto Bergamaschi; Francesco Patti

12.45 - 13.00 - Maria Pia Amato
E-MUSIC: Early MUltiple Sclerosis Italian Cohort
13.00 - 13.15 - Damiano Baroncini
Assessing the clinical course of pediatric onset multiple sclerosis in different treatment eras: are we really modifying the disease?

CONCLUSIONS